Krishna Institute of Medical Sciences Limited has informed the Exchange regarding 'Limited Review Reports on Standalone & Consolidated financials for the quarter and half year ended September 30, 2025.'.
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krishna Institute of Medical Sciences (KIMS) has submitted the Limited Review Reports by its statutory auditors on its standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025. This is a routine regulatory intimation confirming that the limited review (a preliminary check by auditors, not a full audit) has been completed and filed with the stock exchange. The actual financial numbers, commentary, or any qualifications by the auditors are not included in this filing. Investors should look at the accompanying financial results filing for detailed numbers and any auditor observations.
This is a procedural filing and does not by itself indicate any positive or negative outcome. Shareholders should review the actual Q2/H1 FY26 results and any remarks in the limited review report to assess the company's performance.